| Haemonetics |
Vascade MVP Venous Vascular Closure System (VVCS)
|
Extravascular, bioabsorbable closure device |
6–12 inner diameter (up to 15 maximum outer diameter) |
Utilizes existing procedural sheath |
Femoral venous access sites: 6–12-F inner diameter (up to 15-F maximum outer diameter) |
Fully integrated, extravascular, bioabsorbable femoral venous closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the AMBULATE trial, a prospective, multicenter, randomized clinical trial comparing Vascade MVP to manual compression; the Vascade MVP system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; a multiaccess site indication is required for vascular closure devices to provide hemostasis in procedures that require more than one access site in the same vessel such as cardiac ablations (Vascade MVP venous vascular closure system is indicated for this use) |
| Haemonetics |
Vascade Vascular Closure System (VCS)
|
Extravascular, bioabsorbable closure device |
5, 6, 7 |
Utilizes existing procedural sheath |
Femoral arterial and femoral venous access sites (5, 6, or 7 F) |
Fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the RESPECT trial, a prospective, multicenter, randomized clinical trial comparing Vascade to manual compression; the system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; it enables rapid hemostasis while minimizing complications |